|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Octapharma AG Hosts Symposium at World Federation of Hemophilia World Congress on "Personalizing the Inhibitor Treatment and Prevention" in Hemophilia A
7/25/2012 10:15:36 AM
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, a leading producer of human proteins for life saving therapies, proudly sponsored an octanate® symposium “Personalizing the Inhibitor Treatment and Prevention: New Pieces to an Old Puzzle” on July 10th, 2012 at the 30th World Federation of Haemophilia (WFH) Congress in Paris. Over 520 attendees participated in the lunch symposium about inhibitor treatment and prevention in haemophilia A patients. Presented by renowned experts in the field, the symposium was chaired by Manuel Carcao, MD Doctor at the Hospital for Sick Children in Toronto, Canada, and co-chaired by Yves Gruel, Professor at the Trousseau University Hospital in Tours, France.
|
|
|
|
|
|
|
|
|
|
|